235 related articles for article (PubMed ID: 37031809)
1. An overview of topical lipid-based and polymer-based nanocarriers for treatment of psoriasis.
Aziz Hazari S; Kaur H; Karwasra R; Abourehab MAS; Ali Khan A; Kesharwani P
Int J Pharm; 2023 May; 638():122938. PubMed ID: 37031809
[TBL] [Abstract][Full Text] [Related]
2. Understanding the prospective of nano-formulations towards the treatment of psoriasis.
Pradhan M; Alexander A; Singh MR; Singh D; Saraf S; Saraf S; Ajazuddin
Biomed Pharmacother; 2018 Nov; 107():447-463. PubMed ID: 30103117
[TBL] [Abstract][Full Text] [Related]
3. Exploring the potential of nanocarriers in antipsoriatic therapeutics.
Shaif M; Kushwaha P; Usmani S; Pandey S
J Dermatolog Treat; 2022 Nov; 33(7):2919-2930. PubMed ID: 35729857
[TBL] [Abstract][Full Text] [Related]
4. An Innovative Approach in Nanotechnology-based Delivery System for the Effective Management of Psoriasis.
Parveen S; Ahmed M; Baboota S; Ali J
Curr Pharm Des; 2022; 28(13):1082-1102. PubMed ID: 35105284
[TBL] [Abstract][Full Text] [Related]
5. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.
Gungor S; Rezigue M
Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078
[TBL] [Abstract][Full Text] [Related]
6. Topical Drug Delivery of Anti-infectives Employing Lipid-Based Nanocarriers: Dermatokinetics as an Important Tool.
Thakur K; Sharma G; Singh B; Katare OP
Curr Pharm Des; 2018; 24(43):5108-5128. PubMed ID: 30657036
[TBL] [Abstract][Full Text] [Related]
7. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics for the treatment of psoriasis.
Katari O; Jain S
Expert Opin Drug Deliv; 2021 Dec; 18(12):1857-1872. PubMed ID: 34823429
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology-based alternatives for the topical delivery of immunosuppressive agents in psoriasis.
Gomes GS; Frank LA; Contri RV; Longhi MS; Pohlmann AR; Guterres SS
Int J Pharm; 2023 Jan; 631():122535. PubMed ID: 36566826
[TBL] [Abstract][Full Text] [Related]
9. Liposome Based Drug Delivery for the Management of Psoriasis - A Comprehensive Review.
Bahadur S; Sharma M
Curr Pharm Biotechnol; 2023; 24(11):1383-1396. PubMed ID: 36518042
[TBL] [Abstract][Full Text] [Related]
10. Lipid-based nanoparticles for psoriasis treatment: a review on conventional treatments, recent works, and future prospects.
Mohd Nordin UU; Ahmad N; Salim N; Mohd Yusof NS
RSC Adv; 2021 Aug; 11(46):29080-29101. PubMed ID: 35478537
[TBL] [Abstract][Full Text] [Related]
11. Comprehending the potential of metallic, lipid, and polymer-based nanocarriers for treatment and management of depression.
Patel RB; Rao HR; Thakkar DV; Patel MR
Neurochem Int; 2022 Feb; 153():105259. PubMed ID: 34942308
[TBL] [Abstract][Full Text] [Related]
12. A Promising Approach of Dermal Targeting of Antipsoriatic Drugs
Tripathi D; Srivastava M; Rathour K; Rai AK; Wal P; Sahoo J; Tiwari RK; Pandey P
Drug Metab Bioanal Lett; 2023; 16(2):89-104. PubMed ID: 37534794
[TBL] [Abstract][Full Text] [Related]
13. Trends in nanotechnology-based delivery systems for dermal targeting of drugs: an enticing approach to offset psoriasis.
Saleem S; Iqubal MK; Garg S; Ali J; Baboota S
Expert Opin Drug Deliv; 2020 Jun; 17(6):817-838. PubMed ID: 32315216
[TBL] [Abstract][Full Text] [Related]
14. Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches.
Pradhan M; Singh D; Singh MR
J Control Release; 2013 Sep; 170(3):380-95. PubMed ID: 23770117
[TBL] [Abstract][Full Text] [Related]
15. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
[TBL] [Abstract][Full Text] [Related]
16. Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity.
Raza K; Singh B; Lohan S; Sharma G; Negi P; Yachha Y; Katare OP
Int J Pharm; 2013 Nov; 456(1):65-72. PubMed ID: 23973754
[TBL] [Abstract][Full Text] [Related]
17. Recent Advancements in Topical Anti-Psoriatic Nanostructured Lipid Carrier-Based Drug Delivery.
Patil TS; Gujarathi NA; Aher AA; Pachpande HE; Sharma C; Ojha S; Goyal SN; Agrawal YO
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769305
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy.
Rahman M; Akhter S; Ahmad J; Ahmad MZ; Beg S; Ahmad FJ
Expert Opin Drug Deliv; 2015 Apr; 12(4):635-52. PubMed ID: 25439967
[TBL] [Abstract][Full Text] [Related]
19. Novel Topical Nanocarriers for Treatment of Psoriasis: An Overview.
Dadwal A; Mishra N; Narang RK
Curr Pharm Des; 2018; 24(33):3934-3950. PubMed ID: 30387390
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured Lipid Carriers as Potential Drug Delivery Systems for Skin Disorders.
Waghule T; Rapalli VK; Gorantla S; Saha RN; Dubey SK; Puri A; Singhvi G
Curr Pharm Des; 2020; 26(36):4569-4579. PubMed ID: 32534562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
